PetCaseFinder

Peer-reviewed veterinary case report

Dexmedetomidine infusion for managing post-surgery pain in dogs

By Valtolina, Chiara et al.·Published in Veterinary anaesthesia and analgesia·2009·Department of Clinical Sciences of Companion Animals, Netherlands·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Clinical evaluation of the efficacy and safety of a constant rate infusion of dexmedetomidine for postoperative pain management in dogs.

Species:
dog

Plain-English summary

Forty dogs recovering from surgery were given either a constant rate infusion of dexmedetomidine or morphine to manage their pain. While both treatments were effective, the dogs receiving dexmedetomidine reported less pain during the second half of the 24-hour period. There were no significant side effects noted with either treatment, making dexmedetomidine a safe option for postoperative pain relief. This suggests that dexmedetomidine could be a good alternative or addition to traditional pain medications after surgery.

People also search for: dog postoperative pain management · dexmedetomidine for dogs · morphine side effects in dogs

Abstract

OBJECTIVE: To compare postoperative analgesia provided by a constant rate infusion (CRI) of dexmedetomidine (DMED) to that of a well-established positive control [morphine (MOR)] in critically ill dogs. The sedative, cardiorespiratory effects and clinical safety of a 24-hour DMED CRI were also evaluated. STUDY DESIGN: Prospective, randomised, blinded, positive-controlled parallel-group clinical study. ANIMALS: Forty hospitalised, client-owned dogs requiring post-operative pain management after invasive surgery. METHODS: After surgery, a loading dose of either DMED (25 microg m(-2)) or MOR (2500 microg m(-2)) followed by a 24-hour CRI of DMED (25 microg m(-2) hour(-1)) or MOR (2500 microg m(-2) hour(-1)) was administered. Pain was measured using the Short Form of the Glasgow Composite Measure Pain Scale, sedation and physiological variables were scored at regular intervals. Animals considered to be painful received rescue analgesia and were allocated to a post-rescue protocol; animals which were unresponsive to rescue analgesia were removed from the study. Data were analysed with anova, two-sample t-tests or Chi-square tests. Time to intervention was analysed with Kaplan-Meier methodology. RESULTS: Forty dogs were enrolled. Twenty dogs (9 DMED and 11 MOR) did not require rescue analgesia. Eleven DMED and eight MOR dogs were allocated to the post-rescue protocol and seven of these removed from the study. Significant differences in pain scores between groups were not observed during the first 12 hours, however, DMED dogs were less (p = 0.009) painful during the last 12 hours. Sedation score over the entire 24-hour study was not significantly different between groups. CONCLUSION / CLINICAL RELEVANCE: Dexmedetomidine CRI was equally effective as MOR CRI at providing postoperative analgesia and no clinically significant adverse reactions were noted. This study shows the potential of DMED to contribute to a balanced postoperative analgesia regimen in dogs.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/19470144/